Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)

被引:41
|
作者
Doebele, R. [1 ]
Ahn, M. [2 ]
Siena, S. [3 ,4 ]
Drilon, A. [5 ]
Krebs, M. [6 ]
Lin, C. [7 ]
De Braud, F. [8 ]
John, T. [9 ]
Tan, D. [10 ]
Seto, T. [11 ]
Dziadziuszko, R. [12 ]
Arkenau, H. [13 ]
Barlesi, F. [14 ]
Rolfo, C. [15 ]
Wolf, J. [16 ]
Chow-Maneval, E. [17 ]
Multani, P. [17 ]
Cui, N. [18 ]
Riehl, T. [18 ]
Cho, B. C. [9 ]
机构
[1] Univ Colorado, Aurora, CO USA
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, Seoul, South Korea
[3] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Milan, Italy
[4] Univ Milan, Milan, Italy
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA
[6] Univ Manchester, Manchester, Lancs, England
[7] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[8] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[9] Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea
[10] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore
[11] Natl Kyushu Canc Ctr, Dept Thorac Oncol, Fukuoka, Fukuoka, Japan
[12] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland
[13] Sarah Cannon Res Inst, London, England
[14] Aix Marseille Univ, AP HM, Marseille, France
[15] Antwerp Univ Hosp, Oncol Dept, Phase 1 Early Clin Trials Unit, Antwerp, Belgium
[16] Univ Hosp Cologne, Ctr Integrated Oncol Koln Bonn, Cologne, Germany
[17] Ignyta Inc, San Diego, CA USA
[18] Genentech Inc, San Francisco, CA USA
关键词
NSCLC; entrectinib; ROS1 gene fusion;
D O I
10.1016/j.jtho.2018.08.239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA02.01
引用
收藏
页码:S321 / S322
页数:2
相关论文
共 50 条
  • [1] Entrectinib in Patients with Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
    Ahn, M.
    Cho, B. C.
    Siena, S.
    Drilon, A.
    De Braud, F.
    Krebs, M.
    John, T.
    Karapetis, C.
    Johnson, A.
    Chow-Maneval, E.
    Multani, P.
    Doebele, R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1783 - S1783
  • [2] Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
    Dziadziuszko, Rafal
    Krebs, Matthew G.
    De Braud, Filippo
    Siena, Salvatore
    Drilon, Alexander
    Doebele, Robert C.
    Patel, Manish R.
    Cho, Byoung Chul
    Liu, Stephen V.
    Ahn, Myung-Ju
    Chiu, Chao-Hua
    Farago, Anna F.
    Lin, Chia-Chi
    Karapetis, Christos S.
    Li, Yu-Chung
    Day, Bann-mo
    Chen, David
    Wilson, Timothy R.
    Barlesi, Fabrice
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1253 - +
  • [3] Efficacy and safety of entrectinib in locally advanced/metastatic ROS1 fusion-positive NSCLC: An updated integrated analysis
    Krebs, M. G.
    De Braud, F.
    Siena, S.
    Drilon, A.
    Doebele, R. C.
    Patel, M. R.
    Cho, B. C.
    Liu, S. V.
    Ahn, M-J.
    Chiu, C-H.
    Farago, A. F.
    Lin, C-C.
    Karapetis, C. S.
    Li, Y-C.
    Barlesi, F.
    Simmons, B.
    Pitcher, B.
    Dziadziuszko, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S831 - S833
  • [4] Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/ metastatic NTRK fusion-positive (fp) non-small cell lung cancer (NSCLC)
    Cho, Byoung Chul
    Chiu, Chao-Hua
    Massarelli, Erminia
    Buchschacher, Gary L.
    Goto, Koichi
    Overbeck, Tobias R.
    Loong, Herbert H. F.
    Chee, Cheng E.
    Garrido, Pilar
    Heinzmann, Sebastian
    Bordogna, Walter
    Zeuner, Harald
    Osborne, Stuart
    John, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
    Fan, Yun
    Drilon, Alexander
    Chiu, Chao-Hua
    Loong, Herbert H. F.
    Siena, Salvatore
    Krzakowski, Maciej
    Dziadziuszko, Rafal
    Zeuner, Harald
    Xue, Cloris
    Krebs, Matthew G.
    CLINICAL LUNG CANCER, 2024, 25 (02) : e81 - e86.e4
  • [6] Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: of response by line of therapy
    Liu, S. V.
    De Braud, F.
    Drilon, A.
    Doebele, R. C.
    Patel, M. R.
    Cho, B. C.
    Ahn, M-J.
    Chiu, C-H.
    Farago, A. F.
    Goto, K.
    Lee, J.
    Ohe, Y.
    Ou, S-H. I.
    Cassier, P.
    Tan, D. S. W.
    Otterson, G. A.
    Veronese, L.
    Osborne, S.
    Simmons, B.
    Siena, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S472 - S473
  • [7] Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC
    Drilon, Alexander
    Chiu, Chao-Hua
    Fan, Yun
    Cho, Byoung Chul
    Lu, Shun
    Ahn, Myung-Ju
    Krebs, Matthew G.
    Liu, Stephen, V
    John, Thomas
    Otterson, Gregory A.
    Tan, Daniel S. W.
    Patil, Tejas
    Dziadziuszko, Rafal
    Massarelli, Erminia
    Seto, Takashi
    Doebele, Robert C.
    Pitcher, Bethany
    Kurtsikidze, Nino
    Heinzmann, Sebastian
    Siena, Salvatore
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 3 (06):
  • [8] Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
    Barlesi, F.
    Drilon, A.
    De Braud, F.
    Cho, B. C.
    Ahn, M. J.
    Siena, S.
    Krebs, M. G.
    Lin, C. C.
    John, T.
    Tan, D. S. W.
    Seto, T.
    Dziadziuszko, R.
    Arkenau, H-T.
    Rolfo, C.
    Wolf, J.
    Ye, C.
    Riehl, T.
    Eng, S.
    Doebele, R. C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
    Drilon, Alexander
    Barlesi, Fabrice
    De Braud, Filippo
    Cho, Byoung Chul
    Ahn, Myung-Ju
    Siena, Salvatore
    Krebs, Matthew G.
    Lin, Chia-Chi
    John, Tom
    Tan, Daniel S. W.
    Seto, Takashi
    Dziadziuszko, Rafal
    Arkenau, Hendrick-Tobias
    Rolfo, Christian
    Wolf, Juergen
    Ye, Chenglin
    Riehl, Todd
    Eng, Susan
    Doebele, Robert C.
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
    Cho, Byoung Chul
    Chiu, Chao-Hua
    Massarelli, Erminia
    Buchschacher, Gary L.
    Goto, Koichi
    Overbeck, Tobias R.
    Loong, Herbert H. F.
    Chee, Cheng E.
    Garrido, Pilar
    Dong, Xiaorong
    Fan, Yun
    Lu, Shun
    Schwemmers, Sven
    Bordogna, Walter
    Zeuner, Harald
    Osborne, Stuart
    John, Thomas
    LUNG CANCER, 2024, 188